Skip to content

Serratus Plane Block in Preventing Postoperative Pain of Mastectomy

The Effect of Serratus Plane Block in Preventing Postoperative Pain and Chronic Pain After Breast Cancer Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03615430
Enrollment
50
Registered
2018-08-03
Start date
2018-08-01
Completion date
2019-12-01
Last updated
2020-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Chronic Pain, Serratus Plane Block

Brief summary

A prospective, double-blinded randomized controlled, 1-year follow-up study was designed to compare the analgesic effect of serratus plane block (SPB) after breast cancer surgery. Women undergoing radical mastectomy were dIvided into Control group and SPB group. The postoperative acute pain was evaluated by numerical rating scale (NRS) and the effect of preventing chronic pain was assessed at 3, 6, 12 months after surgery by NRS.

Interventions

PROCEDUREserratus plane block with local anesthetic

The high-frequency linear array ultrasound transducer (UST) was placed parallel to the cephalocaudal axis of the body in T4 levels on the side of the mid-axillary line, identifying latissimus dorsi and serratus anterior, through the thoracic artery to help to find the serratus anterior and 15 ml 0.25% ropivacaine was administered.

PROCEDUREserratus plane block with saline

The high-frequency linear array ultrasound transducer (UST) was placed parallel to the cephalocaudal axis of the body in T4 levels on the side of the mid-axillary line, identifying latissimus dorsi and serratus anterior, through the thoracic artery to help to find the serratus anterior and 15 ml saline was administered.

Sponsors

Feng Xia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* women undergoing radical mastectomy with either sentinel lymph node dissection or axillary lymph node dissection or no axillary lymph node dissection * between the ages of 18 and 85 yr * with an American Society of Anesthesiology (ASA) physical status I or II * without any significant cardiopulmonary, renal and hepatic dysfunction

Exclusion criteria

* Patients with any previous cancer other than breast cancer * occurrence of allergy to local anesthetics * occurrence of opioid-tolerant subjects * occurrence of consuming analgesics, sedatives, antidepressants or any history of substance abuse before surgery

Design outcomes

Primary

MeasureTime frameDescription
Numerical Rating Scale (NRS) of chronic pain3 months after surgeryPain intensity of patients was evaluated by Numerical Rating Scale, rating from 0 (no pain) to 10 (extreme pain) in order to evaluate the effect of SPB in preventing chronic pain

Secondary

MeasureTime frameDescription
the change trend of Numerical Rating Scale (NRS) after surgery0-24 hours after operationPain intensity of patients was evaluated by Numerical Rating Scale, rating from 0 (no pain) to 10 (extreme pain) in order to evaluate the analgesic effect of SPB
Morphine consumption0-24 hours after operationextra need of analgesic

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026